Zobrazeno 1 - 10
of 1 072
pro vyhledávání: '"M. Fellin"'
Publikováno v:
Heritage Science, Vol 12, Iss 1, Pp 1-18 (2024)
Abstract The bronze doors of the Basilica of San Zeno in Verona, Italy, are a special case in art history research. They were made by several workshops during the twelfth century: stylistically, two to three workshops were assumed to produce the meta
Externí odkaz:
https://doaj.org/article/226a0c767ef34d07aeca0a9df21b21a9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ranju Kunwor, Daniel P. Silver, Saveri Bhattacharya, Maysa M. Abu-Khalaf, Ana Maria Lopez, Rebecca Jaslow, Frederick M. Fellin
Publikováno v:
Cancer Research. 81:PS10-41
Background: PARP Inhibitors (inh), Olaparib and Talazoparib, are approved for deleterious germline BRCA mutated (gBRCA+) metastatic breast cancer (MBC). This approval was based on a progression-free survival (PFS) benefit seen in two randomized contr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c43bf36e1ecb225528ea0c1381bc03a
https://doi.org/10.1158/1538-7445.sabcs20-ps10-41
https://doi.org/10.1158/1538-7445.sabcs20-ps10-41
Autor:
Chun Wang, Frederick M. Fellin, Darayus Toorkey, Kaelan Yao, Neha Pancholy, Saveri Bhattacharya, Maysa M. Abu-Khalaf, Ronald E. Myers, Rebecca Jaslow, Daniel P. Silver, Zhong Ye, AnaMaria Lopez, Hushan Yang, Zhenchao Zhang
Publikováno v:
Cancer Research. 80:P6-10
Background: Circulating tumor cells (CTCs) and their clusters (CTC-clusters) are promising prognostic markers in breast cancer. Recently studies showed that platelets interact with tumor cells in the circulation and promote metastasis. However, no st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26723094f401f31b1a54ab3ec007a1bf
https://doi.org/10.1158/1538-7445.sabcs19-p6-10-23
https://doi.org/10.1158/1538-7445.sabcs19-p6-10-23
Autor:
Chun Wang, Bingshan Li, Zhong Ye, Saveri Bhattacharya, Terrence P. Cescon, Hushan Yang, AnaMaria Lopez, Frederick M. Fellin, Maysa M. Abu-Khalaf, Daniel P. Silver, Ronald E. Myers, Qiang Wei, Zhenchao Zhang, Rebecca Jaslow
Publikováno v:
Cancer Research. 80:P4-10
Background: Palbociclib is the first-in-class cyclin dependent kinase (CDK) 4/6 inhibitor approved for the treatment of patients (pts) with hormone receptor (HR) positive/human epidermal growth factor receptor 2 (HER2) negative metastatic breast canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9da4c38b08e44b661776fa5ce8adaf2a
https://doi.org/10.1158/1538-7445.sabcs19-p4-10-27
https://doi.org/10.1158/1538-7445.sabcs19-p4-10-27
Autor:
Ronald E. Myers, Neha Pancholy, Xiaobing Chen, Zhenchao Zhang, Lifang Hou, Hushan Yang, Theodore N. Tsangaris, Chun Wang, Frederick M. Fellin, Zhaomei Mu, Jinliang Xing, Juan P. Palazzo, Manish Neupane, Daniel P. Silver, Qiang Wei, Rebecca Jaslow, Massimo Cristofanilli, Xiuhong Fu, Max Krall, Inna Chervoneva, Adam C. Berger, Saveri Bhattacharya, Shaogui Wan, Laura Austin, Darayus Toorkey, Maysa M. Abu-Khalaf, Zhong Ye, Xiuling Li, Bingshan Li, Kaelan Yao
Publikováno v:
European Journal of Cancer. 106:133-143
BACKGROUND: Both circulating tumor cell (CTC) and total circulating cell-free DNA (ccfDNA) predict cancer patient prognosis. However, no study has explored the prognostic value of the combined use of CTC and ccfDNA. We aimed to investigate individual
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::218bd436286e560c87524dedad565e60
https://doi.org/10.1016/j.ejca.2018.10.012
https://doi.org/10.1016/j.ejca.2018.10.012
Autor:
Paul R. Stauffer, Melissa Lazar, Rita Murphy, Nicole L. Simone, Rebecca Jaslow, Ana Maria Lopez, Daniel P. Silver, Theodore N. Tsangaris, Pramila R. Anne, Matthew J. Schiewer, Saveri Bhattacharya, Allison Zibelli, Mark D. Hurwitz, Adam C. Berger, Alliric I. Willis, Frederick M. Fellin, Maysa Abu Khalaf, Voichita Bar Ad
Publikováno v:
Cancer Research. 80:OT2-03
Background: Chest wall recurrences represent a significant source of morbidity for breast cancer patients causing symptoms including bleeding, ulceration, infection and pain. Approximately 5 to 10% of breast cancer patients undergoing a mastectomy wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47ef7cc22d5af3347ca2f9d2c6b95558
https://doi.org/10.1158/1538-7445.sabcs19-ot2-03-02
https://doi.org/10.1158/1538-7445.sabcs19-ot2-03-02
Autor:
Daniel P. Silver, Weelic Chong, Geetha Jagannathan, Frederick M. Fellin, Kaelan Yao, Terrence P. Cescon, Maysa M. Abu-Khalaf, Chun Wang, Zhaomei Mu, Brian Lu, Manish Neupane, Ana Maria Lopez, Adam C. Berger, Rebecca Jaslow, Massimo Cristofanilli, Saveri Bhattacharya, Ronald E. Myers, Zhenchao Zhang, Qiang Wei, Bingshan Li, Zhong Ye, Theodore N. Tsangaris, Hushan Yang, Lifang Hou, Juan P. Palazzo
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Discordance between HER2 expression in tumor tissue (tHER2) and HER2 status on circulating tumor cells (cHER2) has been reported. It remains largely underexplored whether patients with tHER2(−)/cHER2(+) can benefit from anti-HER2 targeted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abde5f647252f168f9f5b30bb7a065dc
https://pubmed.ncbi.nlm.nih.gov/32367460
https://pubmed.ncbi.nlm.nih.gov/32367460
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.